Asymmetric Dimethylarginine Level in Children Undergoing Bone Marrow Transplantation
Dina Maher Ahmad, Eslam E. Elhawary, Gamal Alden Fathy, Hala Mohamed Nagy, Ibrahim Mohamed Bedraya & Mohamed Ramadan Elshanshory · Journal of Advances in Medicine and Medical Research · 2022
Background: Asymmetric dimethylarginine (ADMA) is a toxic, non‐proteinogenic amino acids formed by post‐translational modification and is a uremic toxin that inhibits nitric oxide (NO) production. The aim of this work was to assess the serum level of asymmetric dimethylarginine i...
Open access
Research Article
10.9734/jammr/2022/v34i1931430